Scott Daniel Cormack, President and CEO at ONCOGENEX PHARMACEUTICALS, INC. (OGXI), sold 3,112 shares at $8.68 ($27K) on 2013-08-19, disclosed to the SEC on 2013-10-07.
Open-market sale of $27k OGXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OGXI | SELL | 2015-06-16 | $12K | — | Filing → |
| OGXI | SELL | 2015-05-21 | $14K | — | Filing → |
| OGXI | SELL | 2014-08-14 | $58K | — | Filing → |